XML 102 R82.htm IDEA: XBRL DOCUMENT v3.20.4
Geneos Therapeutics, Inc. - Deconsolidation Accounting (Details) - USD ($)
3 Months Ended 12 Months Ended
Jun. 01, 2020
Dec. 31, 2020
Sep. 30, 2020
Jun. 30, 2020
Mar. 31, 2020
Dec. 31, 2020
Dec. 31, 2019
Dec. 31, 2018
Noncontrolling Interest [Line Items]                
Fixed assets, net of accumulated depreciation   $ (11,348,144)       $ (11,348,144) $ (12,773,017)  
Carrying value of noncontrolling interest   0       0 1,969,759  
Gain on deconsolidation of Geneos   $ 0 $ 0 $ (4,121,075) $ 0 (4,121,075) 0 $ 0
Decrease in cash resulting from the deconsolidation of Geneos           $ 2,774,851 $ 0 $ 0
Geneos Therapeutics, Inc.                
Noncontrolling Interest [Line Items]                
Working capital (excluding cash) $ (59,992)              
Note payable 171,620              
Fixed assets, net of accumulated depreciation (16,340)              
Carrying value of noncontrolling interest 3,181,640              
Fair value of investment in Geneos retained 3,618,998              
Gain on deconsolidation of Geneos (4,121,075)              
Decrease in cash resulting from the deconsolidation of Geneos $ 2,774,851